Clinical Journal of the American Society of Nephrology (CJASN) podcast

Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management

2024-09-23

Clinical Journal of the American Society of Nephrology (CJASN)

0:00

17:49

CJASN editors highlight three articles centered on the theme of CKD, including articles on SGLT2 inhibitors in CKD patients; SGLT2 inhibitors and cardiovascular death in CKD; and smartphone intervention for lifestyle and hypertension management in CKD.

Fler avsnitt från "Clinical Journal of the American Society of Nephrology (CJASN)"

Comparative Effectiveness of Lubiprostone and Stool Softeners in CKD
2025-10-28
3:53
In this podcast, Dr. Sumida summarizes the main findings from his study on "Comparative Effectiveness of Lubiprostone and Stool Softeners on Risk of Kidney Outcomes in Patients with CKD" on behalf of his coauthors.
SGLT2 Inhibition and Hospitalizations in Patients with Chronic Kidney Disease
2025-09-30
3:47
In this podcast, Dr. Neuen summarizes the main findings from his study on "SGLT2 inhibition and hospitalizations in patients with CKD: Data from CREDENCE and a meta-analysis of CKD progression trials" on behalf of his colleagues.
Missa inte ett avsnitt av “Clinical Journal of the American Society of Nephrology (CJASN)” och prenumerera på det i GetPodcast-appen.
Predictors of Kidney Outcomes in C3 Glomerulopathy and Idiopathic Membranoproliferative Glomerulonephritis
2025-08-27
3:09
In this podcast, Dr. Ghaddar summarizes the main findings from her study on "Clinical and Histologic Predictors of Kidney Outcomes in C3 Glomerulopathy and Idiopathic Membranoproliferative Glomerulonephritis" on behalf of her colleagues.
Perceptions of Future Earnings Among Nephrology Fellows
2025-07-25
3:03
In this podcast, Drs. Raslan and Triozzi summarize the main findings from their study on "Assessing Current Nephrology Fellows' Perceptions of Future Earnings as Attending Physicians" on behalf of their colleagues.
SGLT2 Inhibitors and Risk of Urinary Tract Infections with Abnormal Genitourinary Pathology
2025-06-27
7:23
In this podcast, Drs. Eadon, Zhang, and Xu summarize the main findings from their study on "Risk of Urinary Tract Infections with SGLT2 Inhibitors in Subpopulations with Abnormal Genitourinary Pathology" on behalf of their colleagues.
Transition Practices in Pediatric and Adult Nephrology
2025-04-23
3:41
In this podcast, Dr. Vissing summarizes the main findings from his study on "Bridging the Gap: Assessing Nephrology Transition Practices in Pediatric and Adult Medical Centers" on behalf of his colleagues.
Creatinine and Cystatin-Based Equations in People with Cancer
2025-03-25
5:18
In this podcast, Dr. Titan summarizes the main findings from her study on "Performance of creatinine and cystatin-based equations on estimating measured GFR in people with hematological and solid cancers" on behalf of her colleagues.
GLP1 Receptor Agonists and Kidney Outcomes
2025-02-14
5:01
In this podcast, Dr. Mendonça summarizes the main findings from his study on "The Impact of Glucagon-like Peptide-1 Receptor Agonists on Kidney Outcomes: A Meta-Analysis of Randomized Placebo-Controlled Trials" on behalf of his colleagues.
Anticoagulation and Fracture Risk in CKD Patients with Atrial Fibrillation
2025-01-23
4:01
In this podcast, Drs. Khan and Paik summarize the main findings from their study on "Fracture in association with anticoagulant therapy in patients with chronic kidney disease and atrial fibrillation" on behalf of their colleagues.
Comparing USRDS vs. National Death Index on Sudden Cardiac Death in Dialysis Patients
2024-12-23
5:17
In this podcast, Dr. Shafi and Dr. Obi summarize the main findings from their study on "Comparing USRDS and National Death Index Data on Sudden Cardiac Death in US Dialysis Patients" on behalf of their colleagues.

Fler avsnitt

Kom åt alla poddsändningar i gratisappen GetPodcast.

Prenumerera på dina favoritpoddar, lyssna på avsnitt offline och få spännande rekommendationer.

Sekretesspolicy
Rättsligt meddelande
Sverige

Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management

Clinical Journal of the American Society of Nephrology (CJASN)

Fler avsnitt från "Clinical Journal of the American Society of Nephrology (CJASN)"

Comparative Effectiveness of Lubiprostone and Stool Softeners in CKD

SGLT2 Inhibition and Hospitalizations in Patients with Chronic Kidney Disease

Predictors of Kidney Outcomes in C3 Glomerulopathy and Idiopathic Membranoproliferative Glomerulonephritis

Perceptions of Future Earnings Among Nephrology Fellows

SGLT2 Inhibitors and Risk of Urinary Tract Infections with Abnormal Genitourinary Pathology

Transition Practices in Pediatric and Adult Nephrology

Creatinine and Cystatin-Based Equations in People with Cancer

GLP1 Receptor Agonists and Kidney Outcomes

Anticoagulation and Fracture Risk in CKD Patients with Atrial Fibrillation

Comparing USRDS vs. National Death Index on Sudden Cardiac Death in Dialysis Patients